EMERYVILLE, CA AND RENO, NV (October 18, 2023) — TruTag Technologies, a smart medicine solution
provider, and Daya Medicals, Inc., a leading digital health platform, announced today that they are
forming a partnership to deliver combination digital therapeutics to the pharmaceutical industry.
Brands across the pharmaceutical industry are increasingly embracing digitization as a means of value
enhancement and differentiation. From this digitization, a new classification of combination therapies
has emerged that deliver evidence-based digital interventions to improve health outcomes.
“Digital therapeutics have been clinically proven to improve patient outcomes”, said Justin Daya, CEO of
DayaMed. “The digital transition has already begun, and patient expectations are changing. We are
delighted to embark on this partnership to put patient safety and adherence at the heart of digital
The venture between TruTag and DayaMed will address the needs of pharmaceutical companies seeking
to transition brands to a digital combination therapy. The partnership will couple TruTag’s smart
medicine solution with DayaMed’s comprehensive adherence platform. The result offers a holistic
solution for digitizing medicines, engaging patients and offering a solution to improve health outcomes.
“We are thrilled to be working with a partner of DayaMed’s caliber,” said Barry McDonogh, TruTag’s CEO.
TruTag’s ability to digitize medicines coupled with DayaMed’s expertise in digital patient engagement and
support, will enable us to provide a truly differentiated solution. Market interest is high, and we are
already in the planning stage of our first engagements”.
The venture already has committed customers and patient engagement on the joint platorm will begin
in the first quarter of 2024.